BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10583316)

  • 1. GH substitution does not alter the pulsatile pattern of LH in amenorrhoeic growth hormone deficient women.
    de Boer JA; van der Veen EA; Schoemaker J
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):479-85. PubMed ID: 10583316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea.
    Genazzani AD; Petraglia F; Volpogni C; Pianazzi F; Montanini V; D'Ambrogio G; Genazzani AR
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):607-11. PubMed ID: 8252752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing hormone pulsatile release and the length of lactational amenorrhoea.
    Díaz S; Cárdenas H; Zepeda A; Brandeis A; Schiappacasse V; Miranda P; Serón-Ferré M; Croxatto HB
    Hum Reprod; 1995 Aug; 10(8):1957-61. PubMed ID: 8567822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LH pulse frequency in relation to positive oestrogen-gonadotrophin feedback in amenorrhoea.
    El Sheikh MA; Molloy BG; Oakey RE; Chapman C; Nancock KW; Glass MR
    Clin Endocrinol (Oxf); 1983 May; 18(5):517-25. PubMed ID: 6409461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired reproductive function in women treated for growth hormone deficiency during childhood.
    de Boer JA; Schoemaker J; van der Veen EA
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):681-9. PubMed ID: 9274698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypothalamus and ovary on pituitary function in transgenic mice expressing the bovine growth hormone gene and in growth hormone-deficient Ames dwarf mice.
    Chandrashekar V; Bartke A
    Biol Reprod; 1996 May; 54(5):1002-8. PubMed ID: 8722619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Soules MR
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):285-92. PubMed ID: 8729523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
    Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 24 h pattern of pulsatile luteinizing hormone, follicle stimulating hormone and prolactin release during the first 8 weeks of lactational amenorrhoea in breastfeeding women.
    Tay CC; Glasier AF; McNeilly AS
    Hum Reprod; 1992 Aug; 7(7):951-8. PubMed ID: 1430134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone, and prolactin in late gestation: a new method for the analysis of copulsatility.
    Albers N; Bettendorf M; Herrmann H; Kaplan SL; Grumbach MM
    Endocrinology; 1993 Feb; 132(2):701-9. PubMed ID: 8425489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile, nyctohemeral and entropic characteristics of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions.
    Roelfsema F; Biermasz NR; Veldhuis JD
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):79-87. PubMed ID: 11849250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP; Hatziioanidis AH; Trovas GP; Misichronis GS; Kounadi TG; Devetzaki OA; Andronis CK; Rangou DB; Chlouverakis CS
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.